"Spitalul Clinic Cai Ferate Constanta s-a infiintat prin Ordinul Ministrului Transporturilor si Telecomunicatiilor nr.1044 din 05.08.1980. Necesitatea organizarii si dezvoltarii unei retele sanitare proprii Ministerului Transporturilor, Constructiilor si Infrastructurii rezida din domeniul de activitate al acestei institutii, respectiv transportul feroviar, auto si naval, domeniu de importanta nationala maxima. Ca urmare a adresei nr 6223 din 7 mai 1948, are loc transformarea Dispensarului D.P.M. de pe vremea aceea, in Spital, facandu-se primele demersuri de amenajare si dotare corespunzatoare pentru noua destinatie a spatiului."

During the past decade, Spitalul Clinic Cai Ferate Constanta conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Spitalul Clinic Cai Ferate Constanta" #1 sponsor was "ACADIA Pharmaceuticals Inc." with 2 trials, followed by "Celgene" with 2 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored, "Immunic AG" with 1 trials sponsored and "Jazz Pharmaceuticals" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Spitalul Clinic Cai Ferate Constanta" are "Multiple Sclerosis" (2 trials), "Neuropsychiatric Symptoms Related to Neurodegenerative Disease" (2 trials), "Multiple Sclerosis (MS)" (1 trials), "Multiple Sclerosis, Primary Progressive" (1 trials) and "Parkinson's Disease" (1 trials). Many other conditions were trialed in "Spitalul Clinic Cai Ferate Constanta" in a lesser frequency.

Most popular intervention types in "Spitalul Clinic Cai Ferate Constanta" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Pimavanserin" (2 trials), "IMU-838 (10 mg/day)" (1 trials), "IMU-838 (30 mg/day)" (1 trials) and "IMU-838 (45 mg/day)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Spitalul Clinic Cai Ferate Constanta" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Spitalul Clinic Cai Ferate Constanta". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Spitalul Clinic Cai Ferate Constanta, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Spitalul Clinic Cai Ferate Constanta, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".